Literature DB >> 24999174

Duration of untreated psychosis (DUP) and the course of schizophrenia in a 20-year follow-up study.

Andrzej Cechnicki1, Łukasz Cichocki2, Aneta Kalisz2, Piotr Błądziński2, Przemysław Adamczyk2, Joanna Franczyk-Glita2.   

Abstract

Our aims were to analyze the relationship between the duration of psychosis (DUP) and short- and long-term outcomes of treatment, and to determine the cut-off point between short and long DUP at which differences in treatment outcomes are most significant. We assessed 80 participants with schizophrenia at the point of their first hospitalization. Fifty participated in all four follow-ups over 20 years. DUP was divided into short (up to 6 months) and long (over 6 months). ANOVA and Chi-square tests were employed to identify significant differences in both clinical and social indicators of functioning. ROC curves were used to estimate the best DUP division point. Significant differences favoring the short-DUP group were found for: GAF, total severity of symptoms and severity of positive symptoms, social functioning measured according to DSM-III criteria, employment, and social contacts. The optimal cut-off point for DUP was the 23rd week. We concluded that: (1) the relationship between longer DUP and worse overall treatment outcomes was sustained throughout the 20 years, (2) a positive correlation between DUP and the severity of psychopathological symptoms was observed over the first 12 years of illness, (3) the results indicate the efficacy of early therapeutic interventions in psychosis.
Copyright © 2014. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Long-term study; Predictors; Psychosis

Mesh:

Year:  2014        PMID: 24999174     DOI: 10.1016/j.psychres.2014.05.046

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  16 in total

1.  Persistence of psychosis spectrum symptoms in the Philadelphia Neurodevelopmental Cohort: a prospective two-year follow-up.

Authors:  Monica E Calkins; Tyler M Moore; Theodore D Satterthwaite; Daniel H Wolf; Bruce I Turetsky; David R Roalf; Kathleen R Merikangas; Kosha Ruparel; Christian G Kohler; Ruben C Gur; Raquel E Gur
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

2.  Detecting motor slowing in clinical high risk for psychosis in a computerized finger tapping model.

Authors:  Katherine S F Damme; K Juston Osborne; James M Gold; Vijay A Mittal
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-08-20       Impact factor: 5.270

Review 3.  Clinical predictors of therapeutic response to antipsychotics in schizophrenia.

Authors:  Maren Carbon; Christoph U Correll
Journal:  Dialogues Clin Neurosci       Date:  2014-12       Impact factor: 5.986

4.  Rate of and time to symptomatic remission in first-episode psychosis in Northern Malawi: A STROBE-compliant article.

Authors:  Atipatsa Chiwanda Kaminga; Wenjie Dai; Aizhong Liu; Japhet Myaba; Richard Banda; Shi Wu Wen; Xiongfeng Pan
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

5.  Where to seek help? Barriers to beginning treatment during the first-episode psychosis.

Authors:  Isabela Dos Santos Martin; Bianca Cristina Ciccone Giacon; Kelly Graziani Giacchero Vedana; Ana Carolina Guidorizzi Zanetti; Lorena Fendrich; Sueli Aparecida Frari Galera
Journal:  Int J Nurs Sci       Date:  2018-06-30

Review 6.  Advancing study of cognitive impairments for antipsychotic-naïve psychosis comparing high-income versus low- and middle-income countries with a focus on urban China: Systematic review of cognition and study methodology.

Authors:  Lawrence H Yang; Bernalyn Ruiz; Amar D Mandavia; Margaux M Grivel; Liang Y Wong; Michael R Phillips; Matcheri S Keshavan; Huijun Li; Jeffrey A Lieberman; Ezra Susser; Larry J Seidman; William S Stone
Journal:  Schizophr Res       Date:  2020-04-05       Impact factor: 4.939

7.  Computerized Assessment of Psychosis Risk.

Authors:  Vijay A Mittal; Lauren M Ellman; Gregory P Strauss; Elaine F Walker; Philip R Corlett; Jason Schiffman; Scott W Woods; Albert R Powers; Steven M Silverstein; James A Waltz; Richard Zinbarg; Shuo Chen; Trevor Williams; Joshua Kenney; James M Gold
Journal:  J Psychiatr Brain Sci       Date:  2021-06-29

8.  Utility of Washington Early Recognition Center Self-Report Screening Questionnaires in the Assessment of Patients with Schizophrenia and Bipolar Disorder.

Authors:  Christina J Hsieh; Douglass Godwin; Daniel Mamah
Journal:  Front Psychiatry       Date:  2016-08-26       Impact factor: 4.157

9.  The effect of brexpiprazole in adult outpatients with early-episode schizophrenia: an exploratory study.

Authors:  Ashok Malla; Ai Ota; Kazuhiro Nagamizu; Pamela Perry; Emmanuelle Weiller; Ross A Baker
Journal:  Int Clin Psychopharmacol       Date:  2016-11       Impact factor: 1.659

10.  The impact of waiting time on patient outcomes: Evidence from early intervention in psychosis services in England.

Authors:  Anika Reichert; Rowena Jacobs
Journal:  Health Econ       Date:  2018-07-16       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.